Nasal Swab Medical Laboratory Consumables Nucleic Acid Releaser Disposable CE

Nasal Swab DNA / RNA Nucleic Acid Sample Releaser Disposable Laboratory Consumable kit

Intended use:

Test Principle:
The protein denaturant in this product can break the cell and virus structure under the condition of low ionic strength and alkalinity, denature the protein and release the nucleic acid into the solution.

Product Pictures:

Product components:

Specimen:

1. Specimen type

Nasal swab, nasopharyngeal swab and throat swab.

2. Specimen collection and transportation

Biosafety should be carried out in accordance with relevant regulations.

Extraction Method:

(1) After collecting, put the swab sample into the nucleic acid releasing agent, fully mix it, and place it vertically at room temperature for 5- 10 minutes.

(2) The supernatant was centrifuged as the nucleic acid amplification template for PCR detection.

Note: the volume of template should be less than 25% of the total volume of nucleic acid reaction. I.e. The mixed supernatant added to the reaction system of 20μL shall not exceed 5μL.

Indexes of product:

Appearance inspection: the kit shall have complete components, and the package appearance shall be clean without leakage and damage; Signs and labels shall be legible.

Attention:

1. Please read this manual carefully before the experiment
2. It is not applicable to the detection of samples containing guanidine salt and other inactivated preservation solutions.
3. The collected samples must be fresh and tested in time to improve the detection rate and sensitivity.
4. The samples added with releasing agent shall be tested in time and placed at 4 ℃ for no more than 1h.

Symbols:

Operation details please check from IFU

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.